Doccla, a provider of virtual ward and remote patient monitoring services, has raised £335 million in Series B funding.
The London firm, which featured on our HealthTech 50 ranking this year, will use the funds to consolidate its position in the UK and Ireland while also expanding further around Europe. Its main focus will be France and the DACH region (Germany, Austria and Switzerland).
Doccla currently monitors patients in more than 10 European countries and works with the NHS across more than half of its regions. It recently signed a partnership with Irish government office the Health Service Executive (HSE).
The round was led by Lakestar and featured Elaia as well as existing investors General Catalyst, Bertelsmann Investments and Speedinvest. Lakestar partner Oliver Heimes will join the company’s board.
Doccla’s monitoring across 40 pathways allows medical staff to access patient data in real-time and pre-emptively flag concerning signals, triggering in-person appointments before issues escalate.
“Doccla was founded to provide hospital-level care and support at home for multiple patient profiles across the acuity spectrum: enabling the early discharge of patients, as well as ensuring that for those with chronic care needs, hospital admission might be avoided in the first place,” said founder Martin Ratz.
“Technology-enabled virtual wards deliver great benefits for patients, who can recover at home, while freeing up resources for healthcare providers. Our work has proven immensely valuable to the UK’s National Health Service and we’re excited to scale our European operations.
“At the same time, we see exceptional upside potential for our services in the Life Sciences sector, and will continue to invest in our data science operations.”
Heimes added: “In less than five years Doccla has gone from a research project to establishing itself as the market leader in the UK. We are confident they will not just maintain that position but successfully launch in new markets, whilst diversifying their services.
“Remote patient care delivers proven results and is ushering in new standards in the healthcare systems globally.”